Product Brochure
CeLLogix cellular bone matrix is a viable allogeneic bone allograft containing viable bone-derived cells
CeLLogix is prepared with a novel DMSO-free cryoprotectant, which provides dependable cell identity and the ability to sustain cell viability post-thaw. Final preparation of the cell and bone components yields a product that provides osteoconductive, osteoinductive, and osteogenic properties to enhance the patient’s innate healing response.
CeLLogix contains the three key elements that are ideal for bone formation
An osteoconductive three-dimensional scaffold with cortical and cancellous components.
A demineralized bone scaffold with osteoinductive potential.¹
Viable spine-derived cells to support osteogenesis.
CeLLogix Product Features
Proprietary, optimized bone microparticulate size range of 100-300 μm²
Novel DMSO-free cryoprotectant, with no rinsing and decanting steps required.
Average cell viability exceeds 80% post-thaw¹
Minimum of 150,000 viable cells per cc of allograft post-thaw¹
Convenient handling and preparation time in the OR
Four hour working window for implantation after thaw without loss of cell viability
Product shelf-life is two years from date of processing when stored at -65°C or colder
Reference:
1. Data on file at VIVEX Biologics, Inc.
2. Malinin, T.I., et. al., Particulate bone allograft incorporation in regeneration of osseous defects; importance of particle sizes. The Open Orthopeadics Journal, 2007. 1:19-24.
